Gastrointestinal stromal tumors, version 2.2014.

Published

Journal Article

Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights highlight the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib.

Full Text

Duke Authors

Cited Authors

  • von Mehren, M; Randall, RL; Benjamin, RS; Boles, S; Bui, MM; Casper, ES; Conrad, EU; DeLaney, TF; Ganjoo, KN; George, S; Gonzalez, RJ; Heslin, MJ; Kane, JM; Mayerson, J; McGarry, SV; Meyer, C; O'Donnell, RJ; Pappo, AS; Paz, IB; Pfeifer, JD; Riedel, RF; Schuetze, S; Schupak, KD; Schwartz, HS; Van Tine, BA; Wayne, JD; Bergman, MA; Sundar, H

Published Date

  • June 2014

Published In

Volume / Issue

  • 12 / 6

Start / End Page

  • 853 - 862

PubMed ID

  • 24925196

Pubmed Central ID

  • 24925196

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States